Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
GILD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.00%204.730.0%$1981.02m
NVAXNovavax, Inc. 0.00%110.8278.2%$792.93m
BIIBBiogen, Inc. 0.00%239.301.8%$522.63m
AMGNAmgen, Inc. 0.00%235.361.4%$522.04m
BNTXBioNTech SE 0.00%196.000.0%$501.82m
GILDGilead Sciences, Inc. 0.00%71.771.0%$472.12m
ILMNIllumina, Inc. 0.00%405.143.3%$406.87m
REGNRegeneron Pharmaceuticals, Inc. 0.00%615.242.7%$388.21m
VRTXVertex Pharmaceuticals, Inc. 0.00%234.061.9%$331.63m
SNSSSunesis Pharmaceuticals, Inc. 0.00%3.170.7%$221.59m
EXASEXACT Sciences Corp. 0.00%78.4317.9%$151.61m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%148.508.2%$151.18m
ARNAArena Pharmaceuticals, Inc. 0.00%92.6513.7%$144.29m
INCYIncyte Corp. 0.00%74.882.4%$128.10m
BBIOBridgeBio Pharma, Inc. 0.00%12.750.0%$115.66m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.